From pathogenesis to precision medicine in systemic lupus erythematosus: Emerging biomarkers and targeted interventions

Weiya Lan, Qianwei Lu, Zong Jiang, Wukai Ma, Lei Hou, Danyang Li, Xudong Rui, Fang Tang · 2026

Read From pathogenesis to precision medicine in systemic lupus erythematosus: Emerging biomarkers and targeted interventions by Weiya Lan, Qianwei Lu, Zong Jiang, Wukai Ma, Lei Hou, Danyang Li, Xudong Rui, Fang Tang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13141465.txt.

Description

SummarySystemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by immune dysregulation, autoantibody production, and chronic inflammation, which can potentially damage almost any organ. The estimated worldwide prevalence of SLE ranges from 5 to 7 million, and it is associated with significant morbidity, premature death, and significant global disparities in terms of sex, ethnicity/race, and geography.

Catalog record

CREATORWeiya Lan, Qianwei Lu, Zong Jiang, Wukai Ma, Lei Hou, Danyang Li, Xudong Rui, Fang Tang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE100 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13141465

Browse the full library · About the Tower of Babel